ArticleWorld journal of microbiology & biotechnology2026
Enhanced biodegradation of bisphenol S by laccase encapsulated in copper-nucleotide metal-organic frameworks.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Bisphenol S (BPS) is widely used as a substitute for bisphenol A (BPA) but has also been identified as an endocrine-disrupting compound with considerable biotoxicity. Compared with BPA, BPS exhibits higher chemical stability, and studies on its biodegradation remain limited. In this work, an efficient strategy for BPS biodegradation was developed using a bacterial laccase immobilized in copper-nucleotide metal-organic frameworks (MOFs). The laccase gene from Bacillus licheniformis was heterologously expressed in Escherichia coli, achieving an extracellular activity of 373.8 U/L. The recombinant laccase was purified and subsequently encapsulated in MOFs constructed through the self-assembly of copper ions and nucleotides, including cytidine monophosphate (CMP) and guanosine monophosphate (GMP). After optimization of the immobilization process, the resulting immobilized laccase (Lac@Cu/CGMP) showed enhanced catalytic performance, exhibiting a relative activity of 106.5% compared with the free enzyme. Moreover, Lac@Cu/CGMP displayed improved thermostability, with a longer half-life at 70 °C (3.4 h) than that of the free laccase (2.9 h). Lac@Cu/CGMP achieved 94% degradation of BPS within 1 h and maintained high degradation efficiency after five consecutive reuse cycles. Transformation products were identified by LC-MS, and a plausible degradation pathway was proposed. The biodegradation of BPS involved hydroxylation, deoxygenation, and cleavage of the S-C bond. These results demonstrate that nucleotide-coordinated copper MOFs provide a facile and effective platform for laccase immobilization, highlighting their potential application in the removal of BPS from contaminated environments.
Indexed as
Identifiers
42909715What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.